AptamiR Therapeutics' Unattributed Round

AptamiR Therapeutics raised a round of funding on September 18, 2015.

AptamiR Therapeutics has created an innovative model of virtual and outsourced Drug Research & Development to cure human obesity by developing microRNA-based treatments that target peripheral adipose …

Articles about AptamiR Therapeutics' Unattributed Round: